These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 33667781

  • 1. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
    Benville JR, Compton P, Giordano NA, Cheatle MD.
    Drug Alcohol Depend; 2021 Apr 01; 221():108619. PubMed ID: 33667781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone.
    Leyde S, Price CJ, Colgan DD, Pike KC, Tsui JI, Merrill JO.
    Subst Use Addctn J; 2024 Jul 01; 45(3):423-433. PubMed ID: 38327009
    [Abstract] [Full Text] [Related]

  • 5. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, Diop H, Bharel M, Krans EE, Selk S, Kelly JF, Wilens TE, Taveras EM.
    JAMA Netw Open; 2020 May 01; 3(5):e205734. PubMed ID: 32453384
    [Abstract] [Full Text] [Related]

  • 6. Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
    Nayak SM, Huhn AS, Bergeria CL, Strain EC, Dunn KE.
    Drug Alcohol Depend; 2021 Apr 01; 221():108649. PubMed ID: 33640679
    [Abstract] [Full Text] [Related]

  • 7. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
    Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Edwards RR, Samet JH.
    Drug Alcohol Depend; 2016 Sep 01; 166():26-31. PubMed ID: 27422763
    [Abstract] [Full Text] [Related]

  • 8. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.
    Addict Sci Clin Pract; 2019 Oct 01; 14(1):37. PubMed ID: 31570100
    [Abstract] [Full Text] [Related]

  • 9. The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder.
    Dever JA, Hertz MF, Dunlap LJ, Richardson JS, Wolicki SB, Biggers BB, Edlund MJ, Bohm MK, Turcios D, Jiang X, Zhou H, Evans ME, Guy GP.
    Public Health Rep; 2024 Oct 01; 139(4):484-493. PubMed ID: 38268479
    [Abstract] [Full Text] [Related]

  • 10. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ, Stumbo SP, McCarty D, Mertens J, Weisner C, Green CA.
    Drug Alcohol Depend; 2016 Mar 01; 160():112-8. PubMed ID: 26796596
    [Abstract] [Full Text] [Related]

  • 11. Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity.
    Ross RK, Inose S, Shulman M, Nunes EV, Zalla LC, Burlew AK, Rudolph KE.
    JAMA Netw Open; 2024 Oct 01; 7(10):e2436612. PubMed ID: 39365581
    [Abstract] [Full Text] [Related]

  • 12. Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study.
    Pinhal M, Schreck B, Leboucher J, STIGMA-group, Victorri-Vigneau C, Laforgue EJ, Grall-Bronnec M.
    Addict Sci Clin Pract; 2024 Oct 16; 19(1):74. PubMed ID: 39415293
    [Abstract] [Full Text] [Related]

  • 13. Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.
    Xu KY, Schiff DM, Jones HE, Martin CE, Kelly JC, Bierut LJ, Carter EB, Grucza RA.
    J Gen Intern Med; 2023 Dec 16; 38(16):3499-3508. PubMed ID: 37436568
    [Abstract] [Full Text] [Related]

  • 14. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.
    Hadland SE, Bagley SM, Rodean J, Silverstein M, Levy S, Larochelle MR, Samet JH, Zima BT.
    JAMA Pediatr; 2018 Nov 01; 172(11):1029-1037. PubMed ID: 30208470
    [Abstract] [Full Text] [Related]

  • 15. Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage.
    Calcaterra SL, Lockhart S, Natvig C, Mikulich S.
    J Hosp Med; 2023 Oct 01; 18(10):896-907. PubMed ID: 37608527
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An Appraisal of Using Opioids in Patients with Opioid Use Disorder.
    Smith RG.
    J Am Podiatr Med Assoc; 2023 Oct 01; 113(3):. PubMed ID: 37463194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multimodal assessment of sleep in men and women during treatment for opioid use disorder.
    Finan PH, Mun CJ, Epstein DH, Kowalczyk WJ, Phillips KA, Agage D, Smith MT, Preston KL.
    Drug Alcohol Depend; 2020 Feb 01; 207():107698. PubMed ID: 31816489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.